AMN

SEC source: 0001209191-22-002036 · doc4.xml · nonDerivative · entry 3

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,093

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

SEC source: 0001209191-22-001999 · doc4.xml · derivative · entry 8

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,111

Underlying: Common Stock · 1,531 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F7 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 4, 2021 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-22-001999 · doc4.xml · nonDerivative · entry 6

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,984

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-22-001999 · doc4.xml · nonDerivative · entry 5

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,330

F3 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 3, 2019. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2018 for the 3-year period beginning on January 1, 2019 and ended December 31, 2021 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 4, 2022. The Company's Relative TSR measured in the 78th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-22-001999 · doc4.xml · nonDerivative · entry 4

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,747

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-22-001999 · doc4.xml · nonDerivative · entry 3

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,195

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

SEC source: 0001209191-22-002147 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,153

F2 · kind: Number of shares withheld for tax purposes.

F3 · balance_after: The number of shares reflected in this column does not include 101,243 vested RSUs that the Reporting Person elected to defer at the time of grant until her separation from service with the Company.

SEC source: 0001209191-22-002147 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,200

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 3, 2019. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2018 for the 3-year period beginning on January 1, 2019 and ended December 31, 2021 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 4, 2022. The Company's Relative TSR measured in the 78th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-22-002036 · doc4.xml · derivative · entry 7

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,326 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 3, 2019 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-22-002036 · doc4.xml · nonDerivative · entry 2

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,809

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-22-002036 · doc4.xml · nonDerivative · entry 1

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,343

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

SEC source: 0001209191-22-001999 · doc4.xml · derivative · entry 7

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,379 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 3, 2019 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-22-001999 · doc4.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,664

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-22-001999 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,131

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

SEC source: 0001209191-21-071319 · doc4.xml · nonDerivative · entry 3

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,997

F5 · kind: The sale of 3,238 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F6 · price: The price reported in this row represents a weighted average price of $119.6574 per share. These shares were sold in multiple transactions at prices ranging from $119.080 to $119.985, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-21-071319 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,235

F3 · kind: The sale of 8,924 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · price: The price reported in this row represents a weighted average price of $120.3853 per share. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.91, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-21-071319 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,159

F1 · kind: The sale of 492 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $121.195 per share. These shares were sold in multiple transactions at prices ranging from $121.06 to $121.33, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-21-070642 · doc4.xml · derivative · entry 9

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,543 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The RSUs reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F8 · derivative.exercise_date: The RSUs reflected in this row were granted on December 17, 2018 and vest on the first, second and third anniversary of the grant date.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-070642 · doc4.xml · nonDerivative · entry 6

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,651

F2 · kind: Number of shares withheld for tax purposes.

F3 · balance_after: The number of shares reflected in this column does not include 101,243 vested RSUs that the Reporting Person elected to defer at the time of grant until her separation from service with the Company.

SEC source: 0001209191-21-070642 · doc4.xml · nonDerivative · entry 5

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,620

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-21-070642 · doc4.xml · derivative · entry 8

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,057

Underlying: Common Stock · 6,849 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The RSUs reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F7 · derivative.exercise_date: The RSUs reflected in this row were granted on December 16, 2019 and vest on the first, second and third anniversary of the grant date.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-070642 · doc4.xml · derivative · entry 7

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,149

Underlying: Common Stock · 6,476 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The RSUs reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs reflected in this row were granted on December 16, 2020 and vest on the first, second and third anniversary of the grant date.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-070642 · doc4.xml · nonDerivative · entry 4

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,077

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-21-070642 · doc4.xml · nonDerivative · entry 3

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,773

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-21-070642 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,924

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-21-070642 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,473

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-21-070062 · doc4.xml · derivative · entry 1

Caballero Jorge A. · CIK 0001899928 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 437

Underlying: Common Stock · 437 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units were granted upon Mr. Caballero's appointment to the Company's Board of Directors on December 14, 2021 and vest on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the Company's 2022 Annual Meeting of Shareholders.

F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-21-065297 · doc4.xml · nonDerivative · entry 1

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,072

F1 · kind: The reporting person transferred 250 shares of AMN Common Stock as a gift to charity.

F2 · balance_after: The number of shares reflected in this column does not include 34,738 vested RSUs that the Reporting Person elected to defer at the time of grant until his retirement from the Board of Directors.

SEC source: 0001209191-21-062658 · doc4.xml · derivative · entry 1

Knudson Jeffrey R · CIK 0001752946 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,262

Underlying: Common Stock · 29,262 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units reflected in this row were granted on November 2, 2021 and vest on the first, second and third anniversary of the grant date and the grantee's provision of three periods of credited service.

F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-21-057552 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,752

F1 · kind: The sale of 1,000 shares of Common Stock set forth in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-21-057308 · doc4.xml · derivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,717

Underlying: Common Stock · 30,717 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units (RSUs) reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs reflected in this row were granted on September 20, 2021 and vest on the first, second and third anniversary of the grant date.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-056806 · doc4.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,752

F1 · kind: The sale of 1,000 shares of Common Stock set forth in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The price reported in this row represents a weighted average price of $111.7351 per share. These shares were sold in multiple transactions at prices ranging from $110.70 to $113.295, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-21-056806 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,752

F1 · kind: The sale of 1,000 shares of Common Stock set forth in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $111.6327 per share. These shares were sold in multiple transactions at prices ranging from $110.70 to $113.295, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-21-050796 · doc4.xml · nonDerivative · entry 2

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,322

F1 · kind: The reporting person transferred 1,000 shares of AMN Common Stock as a gift to charity.

F2 · balance_after: The number of shares reflected in this column does not include 34,738 vested RSUs that the Reporting Person elected to defer at the time of grant until his retirement from the Board of Directors.

SEC source: 0001209191-21-050796 · doc4.xml · nonDerivative · entry 1

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,322

SEC source: 0001209191-21-047939 · doc4.xml · nonDerivative · entry 1

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,351

F1 · kind: The sale of 5,000 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-21-043781 · doc4.xml · nonDerivative · entry 1

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,351

F1 · kind: 1. The sale of 2,500 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-21-043679 · doc4.xml · derivative · entry 3

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,629 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The RSUs identified in this row were granted on June 27, 2018 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-043679 · doc4.xml · nonDerivative · entry 2

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,017

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-21-043679 · doc4.xml · nonDerivative · entry 1

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,103

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-21-040544 · doc4.xml · nonDerivative · entry 1

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,276

F1 · price: The price reported in this row represents a weighted average price of $95.017 per share. These shares were sold in multiple transactions at prices ranging from $95.00 to $95.091, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F2 · balance_after: The number of shares reflected in this column does not include 24,597 vested RSUs that the Reporting Person elected to defer at the time of grant until his retirement from the Board of Directors.

SEC source: 0001209191-21-040015 · doc4.xml · nonDerivative · entry 1

WHEAT DOUGLAS D · CIK 0001158599 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,826

F1 · balance_after: The number of shares reflected in this column does not include 34,738 vested RSUs that the Reporting Person elected to defer at the time of grant until his retirement from the Board of Directors.

SEC source: 0001209191-21-034033 · doc4.xml · nonDerivative · entry 1

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,474

SEC source: 0001209191-21-071319 · doc4.xml · nonDerivative · entry 4

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,750

F7 · kind: The reporting person transferred 6,247 shares of AMN Common Stock as a gift to charity.

F8 · balance_after: The number of shares reflected in this column does not include 101,243 vested RSUs that the Reporting Person elected to defer at the time of grant until her separation from service with the Company.

SEC source: 0001209191-21-032493 · doc4.xml · nonDerivative · entry 1

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,851

F1 · price: The price reported in this row represents a weighted average price of $92.1295 per share. These shares were sold in multiple transactions at prices ranging from $91.89 to $92.49, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-21-032474 · doc4.xml · nonDerivative · entry 1

Marsh Martha H. · CIK 0001500281 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,901

SEC source: 0001209191-21-028097 · doc4.xml · derivative · entry 3

WHEAT DOUGLAS D · CIK 0001158599 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,139

Underlying: Common Stock · 2,139 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2021 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2022.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-028097 · doc4.xml · derivative · entry 2

WHEAT DOUGLAS D · CIK 0001158599 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,826 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 22, 2020 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2021. Accordingly, the number of RSUs identified in this row vested on April 21, 2021, which was the date of the Company's Annual Meeting of Shareholders in 2021.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-028097 · doc4.xml · nonDerivative · entry 1

WHEAT DOUGLAS D · CIK 0001158599 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,733

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-21-028095 · doc4.xml · derivative · entry 1

Trent-Adams Sylvia · CIK 0001826381 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,139

Underlying: Common Stock · 2,139 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2021 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2022.

F3 · derivative.expiration_date: RSUs do not have an expiration date.